Journal
ONCOIMMUNOLOGY
Volume 2, Issue 1, Pages -Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/onci.22059
Keywords
adoptive T cell therapy; cyclophosphamide; immunostimulatory chemotherapy; melanoma; tumor escape
Categories
Funding
- NATIONAL CANCER INSTITUTE [R01CA107082] Funding Source: NIH RePORTER
- NCI NIH HHS [R01 CA107082] Funding Source: Medline
Ask authors/readers for more resources
Adoptive T-cell transfer is among the most promising immunotherapies against cancer. To continue increasing the potential of this therapy, our studies focus on the inhibition of tumor recurrence. Recently, we have demonstrated several ways in which combination therapies involving multiple T-cell populations and immunostimulatory chemotherapy can enhance long-term survival.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available